Philipson, Tomas J.
Tomas J. Philipson American economist
VIAF ID: 7474434 ( Personal )
Permalink: http://viaf.org/viaf/7474434
Preferred Forms
- 200 _ | ‡a Philipson ‡b Tomas J.
-
- 100 1 _ ‡a Philipson, Tomas J
- 100 1 _ ‡a Philipson, Tomas J.
- 100 1 _ ‡a Philipson, Tomas J.
- 100 1 _ ‡a Philipson, Tomas J.
- 100 1 _ ‡a Philipson, Tomas J.
-
-
-
- 100 0 _ ‡a Tomas J. Philipson ‡c American economist
4xx's: Alternate Name Forms (17)
5xx's: Related Names (13)
- 510 2 _ ‡a American Enterprise Institute
- 510 2 _ ‡a Irving B. Harris Graduate School of Public Policy Studies (Chicago, Ill.)
- 510 2 _ ‡a Irving B. Harris Graduate School of Public Policy Studies ‡9 g:Chicago, Ill. ‡e Affiliation
- 510 2 _ ‡a Manhattan Institute
- 510 2 _ ‡a National Bureau of Economic Research
- 510 2 _ ‡a National Bureau of Economic Research (Cambridge, Mass.)
- 510 2 _ ‡a National Bureau of Economic Research (NBER)
- 510 2 _ ‡a National Bureau of Economic Research ‡9 g:Cambridge, Mass. ‡e Affiliation
- 510 2 _ ‡a Rand Corporation
- 510 2 _ ‡a Rand Corporation ‡e Affiliation
- 510 2 _ ‡a University (Chicago, Ill.) ‡b Department of Economics
- 510 2 _ ‡a University of Chicago / Harris School of Public Policy
- 510 2 _ ‡a University ‡9 g:Chicago, Ill. ‡b Department of Economics ‡e Affiliation
Works
Title | Sources |
---|---|
Aging and the growth of long-term care, c1999: | |
Assessing the safety and efficacy of the FDA : the case of the prescription drug user fee acts | |
Can medical progress be sustained? implications of the link between development and output markets | |
Data markets and optimal sample size determination | |
The dual effects of intellectual property regulations : within- and between- patent competition in the US pharmaceuticals industry | |
Economic epidemiology and infectious diseases | |
Health and wealth disparities in the United States | |
The impact of comparative effectiveness research on health and health care spending | |
The impact of public testing for human immunodeficiency virus | |
Innovation and technology adoption in health care markets | |
Is the food and drug administration safe and effective? | |
Is the obesity epidemic a public health problem? a decade of research on the economics of obesity | |
Nonprofit production and competition | |
Pricing and R&D with related margins | |
Private choices and public health | |
The quantity and quality of life and the evolution of world inequality | |
The rise in old age longevity and the market for long-term care | |
The value of life near its end and terminal care | |
Who benefits from new medical technologies? : estimates of consumer and producer surpluses for HIV/AIDS drugs |